AlveoGene, a company focused on transforming rare respiratory disease outcomes using inhaled gene therapy, announces that the US Food & Drug Administration (FDA) has granted Orphan Drug Designation ...

Orbit Discovery and Evergreen Theragnostics expand research collaboration to advance targeted therapeutics development: Oxford, UK Wednesday, December 4, 2024, 12:00 Hrs [IST] Orb ...

UK and Republic of Korea launch new partnership to improve speed and effectiveness of clinical trials: United Kingdom Wednesday, December 4, 2024, 11:00 Hrs [IST] The UK and the R ...

The UK Government has agreed a contract for more than five million doses of human H5 influenza vaccine to boost the country’s resilience in the event of a possible H5 influenza pandemic. The vaccine, ...

Haemonetics to sell whole blood assets to GVS for $67.1 million: Boston Wednesday, December 4, 2024, 10:00 Hrs [IST] Haemonetics Corporation, a global medical technology company f ...

Karnataka govt suspends DC; withdraws Ringer's lactate solution from all its hospitals on quality grounds: Nandita Vijayasimha, Bengaluru Wednesday, December 4, 2024, 08:00 Hrs [I ...

PMBI blacklists six medicine suppliers in five years for non-compliance with quality standards: Gireesh Babu, New Delhi Wednesday, December 4, 2024, 08:00 Hrs [IST] The Pharmaceut ...

UE LifeSciences soon to launch ‘RaKSA’ to detect breast, cervical & oral cancers across 40,000 PHCs: Our Bureau, New Delhi Wednesday, December 4, 2024, 08:00 Hrs [IST] UE Life ...

Karnataka health dept asks DCGI to investigate & initiate action against Paschim Banga Pharma: Nandita Vijayasimha, Bengaluru Wednesday, December 4, 2024, 08:00 Hrs [IST] The Karn ...

Certainly, the central government has taken a small but crucial step as despite the efforts over the last decade through schemes including the production linked incentive (PLI) scheme, the dependence ...

The revised regulations published on May 1 this year by the National Commission for Indian System of Medicine (NCISM) to assess and regulate the minimum standards and requirements (MSR) for the ...

US FDA grants Orphan Drug Designation to AAVantgarde Bio’s AAVB-081 to treat Usher Syndrome Type 1B retinitis pigmentosa: Milan, Italy Tuesday, December 3, 2024, 16:00 Hrs [IST] ...